← FDA Drug Approvals (Drugs@FDA)
DOLUTEGRAVIR SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2021-03-22
Drug application
- FDA Application #
ANDA214397- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOLUTEGRAVIR SODIUM
- Generic name
- Dolutegravir Sodium
- Active ingredients
- DOLUTEGRAVIR SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MACLEODS PHARMS LTD
- First approval
- 2021-03-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown